Shots:
- The US FDA has granted 510(k) clearance to the next generation NEUROMARK system for pts with chronic rhinitis
- The new system optimizes posterior nasal nerve treatment by providing real-time feedback for accurate electrode placement & confirming treatment delivery, with a flexible shaft & atraumatic leaflets that conform to pts anatomy for maximizing treatment coverage
- NEUROMARK System targets key chronic rhinitis symptoms, such as persistent nasal congestion and rhinorrhea, by using impedance-controlled, low-power radiofrequency energy to disrupt parasympathetic nerve signals
Ref: PRNewswire | Image: Neurent Medical| Press Release
Related News:- J&J MedTech Reports First Patient Enrollment in FORWARD CAD trial of Shockwave Javelin Coronary IVL Catheter
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
